Viewing Study NCT04382950


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2026-05-16 @ 7:12 PM
Study NCT ID: NCT04382950
Status: UNKNOWN
Last Update Posted: 2021-06-09
First Post: 2020-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications
Sponsor:
Organization: